Cann Group Ltd has released a press release.
Appendix 4E & Audited Financial Statements for FY21
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cann
- Cann proceeds with Schedule 3 CBD registration program
- Investor presentation regarding capital raising
- Update on recovery of missing funds
- Cann provides further revenue update
- Appendix 4C - quarterly
Later from Cann
- Results of Share Purchase Plan offer
- Cann granted GMP licence & other regulatory updates
- Cann to begin recruitment for CBD phase 3 clinical trial
- Mildura facility practical completion & ODC permit granted
- Satipharm CBD products get green light from UK FSA
Follow Cann into a list and get an email when it puts out news.
Follow Cann